Stocks News

LAST PRICE
187.7400
TODAY'S CHANGE (%)
Trending Down-9.1600 (-4.6521%)

Bid / Lots
175.8300/ 1
Ask / Lots
194.3400/ 1
Open / Previous Close
195.4200 / 196.9000
Day Range
Low 183.3500
High 196.0000
52 Week Range
Low 176.4800
High 275.0000
Volume
1,499,025
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 12, 2024
- Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing, from 4:44PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:44PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: CRL
  04:44 PM EST, 11/12/2024 (MT Newswires) -- Richard F Wallman, Director, on November 06, 2024, sold 7,621 shares in Charles River Laboratories International (CRL) for $1,647,418. Following the Form 4 filing with the SEC, Wallman has control over a to...
Nov 11, 2024
- DJ Charles River Labs Is Maintained at Hold by TD Cowen, from 11:00AM ET on Monday Nov 11, 2024 by Dow Jones
  11:00AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: CRL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 11, 2024 11:00 ET (16:00 GMT)
- TD Cowen Adjusts Price Target on Charles River Laboratories International to $227 From $203, Maintains Hold Rating, from 9:46AM ET on Monday Nov 11, 2024 by MT Newswires
  9:46AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: CRL
  09:46 AM EST, 11/11/2024 (MT Newswires) -- Charles River Laboratories International (CRL) has an average hold rating and price targets ranging from $151 to $260, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and ...
- Charles River Laboratories to Present at UBS and Jefferies Conferences, from 8:00AM ET on Monday Nov 11, 2024 by Dow Jones
  8:00AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: CRL
  
  Charles River Laboratories to Present at UBS and Jefferies Conferences
  WILMINGTON, Mass.--(BUSINESS WIRE)--November 11, 2024--
  Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the UBS Global Healthcare Conference on Tuesday, November 12(th) , at 10:15 a.m. PT (1:15 p.m. ET), and the Jefferies London Healthcare Conference on Wednesday, November 20(th) , at 2:00 p.m. GMT (9:00 a.m. ET).
Nov 8, 2024
- Barrington Adjusts Price Target on Charles River Laboratories International to $212 From $194, Maintains Outperform Rating, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: CRL
  10:45 AM EST, 11/08/2024 (MT Newswires) -- Charles River Laboratories International (CRL) has an average rating of hold and price targets ranging from $151 to $260, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity a...

Yesterday
- Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BMRN
Nov 14, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BMRN
- DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 12:17PM ET on Thursday Nov 14, 2024 by Dow Jones
  12:17PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: INCY
- Incyte to Present at Upcoming Investor Conference, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: INCY
- RBC Raises Price Target on Incyte to $80 From $72, Keeps Sector Perform Rating, from 7:16AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:16AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: INCY
- RBC Capital Adjusts Price Target on Incyte to $80 From $72, Keeps Sector Perform Rating, from 7:01AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:01AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: INCY
Nov 13, 2024
- Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy, from 1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: EXAS
- Qiagen Partners With McGill University for Microbiome Research, from 6:08AM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:08AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: QGEN

Charles River Laboratories International Inc
NYSE:CRLUnited States

Search Criteria

Nov 12, 2024

Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing, from 4:44PM ET on Tuesday Nov 12, 2024 by MT Newswires

Nov 11, 2024

DJ Charles River Labs Is Maintained at Hold by TD Cowen, from 11:00AM ET on Monday Nov 11, 2024 by Dow Jones

TD Cowen Adjusts Price Target on Charles River Laboratories International to $227 From $203, Maintains Hold Rating, from 9:46AM ET on Monday Nov 11, 2024 by MT Newswires

Charles River Laboratories to Present at UBS and Jefferies Conferences, from 8:00AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 8, 2024

Barrington Adjusts Price Target on Charles River Laboratories International to $212 From $194, Maintains Outperform Rating, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires

Peers Headlines

Yesterday

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires

DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires

DJ Incyte Is Maintained at Sector Perform by RBC Capital, from 12:17PM ET on Thursday Nov 14, 2024 by Dow Jones

Incyte to Present at Upcoming Investor Conference, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones

RBC Raises Price Target on Incyte to $80 From $72, Keeps Sector Perform Rating, from 7:16AM ET on Thursday Nov 14, 2024 by MT Newswires

RBC Capital Adjusts Price Target on Incyte to $80 From $72, Keeps Sector Perform Rating, from 7:01AM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy, from 1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones

Qiagen Partners With McGill University for Microbiome Research, from 6:08AM ET on Wednesday Nov 13, 2024 by MT Newswires